These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. In Vivo CRISPR/Cas9 Gene Editing Corrects Retinal Dystrophy in the S334ter-3 Rat Model of Autosomal Dominant Retinitis Pigmentosa. Bakondi B; Lv W; Lu B; Jones MK; Tsai Y; Kim KJ; Levy R; Akhtar AA; Breunig JJ; Svendsen CN; Wang S Mol Ther; 2016 Mar; 24(3):556-63. PubMed ID: 26666451 [TBL] [Abstract][Full Text] [Related]
9. [CRISPR-Cas9 for muscle dystrophies]. Ballouhey O; Bartoli M; Levy N Med Sci (Paris); 2020 Apr; 36(4):358-366. PubMed ID: 32356712 [TBL] [Abstract][Full Text] [Related]
10. Single AAV-mediated mutation replacement genome editing in limited number of photoreceptors restores vision in mice. Nishiguchi KM; Fujita K; Miya F; Katayama S; Nakazawa T Nat Commun; 2020 Jan; 11(1):482. PubMed ID: 31980606 [TBL] [Abstract][Full Text] [Related]
11. CRISPR-Cas9; an efficient tool for precise plant genome editing. Islam W Mol Cell Probes; 2018 Jun; 39():47-52. PubMed ID: 29621557 [TBL] [Abstract][Full Text] [Related]
12. The Application of CRISPR/Cas9 for the Treatment of Retinal Diseases. Peddle CF; MacLaren RE Yale J Biol Med; 2017 Dec; 90(4):533-541. PubMed ID: 29259519 [TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas9-based epigenome editing: An overview of dCas9-based tools with special emphasis on off-target activity. Tadić V; Josipović G; Zoldoš V; Vojta A Methods; 2019 Jul; 164-165():109-119. PubMed ID: 31071448 [TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas9 System and its Research Progress in Gene Therapy. Liu W; Yang C; Liu Y; Jiang G Anticancer Agents Med Chem; 2019; 19(16):1912-1919. PubMed ID: 31633477 [TBL] [Abstract][Full Text] [Related]
15. Prime Editing: A Novel Cas9-Reverse Transcriptase Fusion May Revolutionize Genome Editing. Flotte TR; Gao G Hum Gene Ther; 2019 Dec; 30(12):1445-1446. PubMed ID: 31860398 [No Abstract] [Full Text] [Related]
16. In vivo genome editing as a potential treatment strategy for inherited retinal dystrophies. Yanik M; Müller B; Song F; Gall J; Wagner F; Wende W; Lorenz B; Stieger K Prog Retin Eye Res; 2017 Jan; 56():1-18. PubMed ID: 27623223 [TBL] [Abstract][Full Text] [Related]
17. The new landscape of retinal gene therapy. Ku CA; Pennesi ME Am J Med Genet C Semin Med Genet; 2020 Sep; 184(3):846-859. PubMed ID: 32888388 [TBL] [Abstract][Full Text] [Related]
18. Application of the gene editing tool, CRISPR-Cas9, for treating neurodegenerative diseases. Kolli N; Lu M; Maiti P; Rossignol J; Dunbar GL Neurochem Int; 2018 Jan; 112():187-196. PubMed ID: 28732771 [TBL] [Abstract][Full Text] [Related]
20. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure. Soriano V AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]